Biofil Chemicals & Pharmaceuticals Limited has informed the Exchange about following events for which disclosure as required under Regulation 30 read with sub-clause 7 of Para A of Part A of Schedule III:1.Confirmation of appointment of Joshi Sahay and Company, Practicing Company Secretary (Unique Code: P2025MP322400 and Peer Review Certificate No.: 6873/2025) as Secretarial Auditor of the Company and fix their remuneration - attached as Annexure-I.2.Confirmation of re-appointment of Mr. Ashok Kumar Ramawat (DIN: 08818263) as Independent Director, for a second term of 5 years commencing from 25th August, 2025 to 24th August, 2030, - attached as Annexure-II. 3.Confirmation of re-appointment of Mr. Satish Beohar (DIN: 09220291) as Independent Director, for a second term of 5 years commencing from 30th June, 2026 to 29th June, 2031, - attached as Annexure-II.4.Confirmation for Change in designation of Mr. Ketan Shah (DIN: 08818212) from Whole Time Director to Chairman and Managing Director - attached as Annexure-III5.Confirmation of appointment of Mr. Smitesh Shah (DIN: 00326182) as a Promoter Non Executive Non-Independent Director of the Company - attached as Annexure-IV.
BIOFILCHEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Biofil Chemicals & Pharmaceuticals has disclosed multiple corporate governance changes approved by shareholders at its 40th AGM held on 27th September 2025. Joshi Sahay and Company has been appointed as the new Secretarial Auditor for a 5-year term (FY 2025-26 to FY 2029-30). Two Independent Directors — Mr. Ashok Kumar Ramawat and Mr. Satish Beohar — have been re-appointed for second 5-year terms. Mr. Ketan Shah's designation has been changed from Whole Time Director to Chairman and Managing Director for a 3-year term effective 12th August 2025. Additionally, Mr. Smitesh Shah has been appointed as a Promoter Non-Executive Non-Independent Director, effective from 23rd August 2025.
This is a routine governance update with no material financial impact, though the entry of another promoter family member (Mr. Smitesh Shah, uncle of CMD Ketan Shah) on the board increases promoter representation. Shareholders are unlikely to see significant stock price movement from this announcement.